• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee




FDA- Xolair (omalizumab) Core Presentation (pdf)




Genetech, Inc / Novartis Pharmaceuticals Corp


Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance


Genetech/Novartis-  Xolair (omalizumab) Core Presentation (pdf)